Kristie F Bjornson

Dr. Kristie F Bjornson


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Physical Therapy
Verified
Journal Article
Open access
PDF file
KBKristie F Bjornson
Kristie F Bjornson
BBBasia Belza
Basia Belza
DKDeborah Kartin
Deborah Kartin
RLRebecca Logsdon
Rebecca Logsdon
JMJohn F McLaughlin
John F McLaughlin
Background and Purpose: Assessment of walking activity in youth with cerebral palsy (CP) has traditionally been “capacity-based.” The purpose of this study was to describe the day-to-day ambulatory activity “performance” of youth with CP compared with youth who were developing typically.Subjects: Eighty-one youth with CP, aged 10 to 13 years, who were categorized as being in Gross Motor Function Classification System (GMFCS) levels I to III and 30 age-matched youth who were developing typically were recruited.Methods: Using a cross-sectional design, participants wore the StepWatch monitor for 7 days while documenting average daily total step counts, percentage of time they were active, ratio of medium to low activity levels, and percentage of time at high activity levels.Results: The youth with CP demonstrated significantly lower levels of all outcomes than the comparison group.Discussion and Conclusion: Daily walking activity and variability decreased as functional walking level (GMFCS level) decreased. Ambulatory activity performance within the context of the daily life for youth with CP appears valid and feasible as an outcome for mobility interventions in CP.

1 July 2007 in Pediatrics
Verified
Journal Article
Open access
PDF file
KBKristie F Bjornson
Kristie F Bjornson
RHRoss Hays
Ross Hays
CGCathy Graubert
Cathy Graubert
RPRobert Price
Robert Price
FWFrancine Won
Francine Won
MCMorty Cohen
Morty Cohen
BACKGROUND. Spasticity is a prevalent disabling clinical symptom for children with cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy was first reported in 1993. Botulinum toxin provides a focal, controlled muscle weakness with reduction in spasticity. Interpretation of the literature is difficult because of the paucity of reliable measures of spasticity and challenges with measuring meaningful functional changes in children with disabilities.OBJECTIVE. This study documents the effects of botulinum toxin A injections into the gastrocnemius muscles in children with spastic diplegia. Outcomes are evaluated across all 5 domains of the National Centers for Medical and Rehabilitation Research domains of medical rehabilitation.METHODS. A randomized, double-masked, placebo-controlled design was applied to 33 children with spastic diplegia with a mean age of 5.5 and Gross Motor Function Classification System Levels of I through III. Participants received either 12 U/kg botulinum toxin A or placebo saline injections to bilateral gastrocnemius muscles. Outcomes were measured at baseline and 3, 8, 12, and 24 weeks after injection.RESULTS. Significant decreases in the electromyographic representation of spasticity were documented 3 weeks after botulinum toxin A treatment. A significant decrease in viscoelastic aspects of spasticity was present at 8 weeks, and subsequent increases in dorsiflexion range were documented at 12 weeks for the botulinum toxin A group. Improvement was found in performance goals at 12 weeks and in maximum voluntary torque and gross motor function at 24 weeks for the botulinum toxin A. There were no significant differences between groups in satisfaction with performance goals, energy expenditure, Ashworth scores, or frequency of adverse effects.CONCLUSIONS. The safety profile of 12 U/kg of botulinum toxin A is excellent. Although physiologic and mechanical effects of treatment with botulinum toxin A were documented with functional improvement at 6 months, family satisfaction with outcomes were no different. Communication is needed to ensure realistic expectations of treatment.

30 September 2013 in Disability and Rehabilitation
Verified
Journal Article
Closed access
PDF file
KBKristie F Bjornson
Kristie F Bjornson
CZChuan Zhou
Chuan Zhou
RSRichard Stevenson
Richard Stevenson
DCDimitri Christakis
Dimitri Christakis
KSKit Song
Kit Song
Purpose: To describe daily walking stride rate patterns of young children with cerebral palsy (CP) as compared to a typically developing youth (TDY) cohort relative to age and functional level. Method: A cross-sectional comparison cohort study compared 209 youth with CP with 368 TDY aged 2–13 years. Youth with CP had Gross Motor Function Classification System (GMFCS) levels I–III with 60% bilateral involvement and 79% spastic. Five days of StepWatch data were averaged and classified into low, moderate and high stride rates. Group differences were examined by t-test and analysis of variance. Results: Children with CP walk significantly less each day than TDY (F = 245, p ≤ 0.001) and differ by GMFCS (F = 1.51, p < 0.001). TDY walk a similar number of strides in low and moderate stride rates each day while youth with CP do not. TDY attained high stride rates (>60 strides/min) for 8 min/d with levels I–III at 4.0, 3.2 and 0.53 min/d, respectively. Conclusions: The relative relationship of walking intensity levels within total daily stride activity differs for youth with CP as compared to TDY. The influence of functional walking ability on walking stride activity levels and intensity does not appear to differ significantly across age groups.

1 January 2008 in Pediatric Physical Therapy
Verified
Journal Article
Closed access
KBKristie F Bjornson
Kristie F Bjornson
BBBasia Belza
Basia Belza
DKDeborah Kartin
Deborah Kartin
RLRebecca Logsdon
Rebecca Logsdon
JMJohn McLaughlin
John McLaughlin
ETElaine Adams Thompson
Elaine Adams Thompson
Purpose: To compare the influence of functional level, ambulatory, and physical activity performance on self-reported health status and quality of life (QOL) of youth with cerebral palsy (CP) and with typical development. Methods: A cross-sectional comparison cohort design was used in 81 youth with CP, ages 10 to 13 years and 30 youth with typical development. Participants wore the StepWatch™ monitor for 7 days and completed the Activity Scale for Kids, Child Health Questionnaire-Child Form, and Youth Quality of Life Questionnaire. Multiple regression analysis was used. Results: Self-reported activity performance influenced self-reported physical (β = 0.36), behavioral (β = 0.32), and emotional (β = 0.29) health. Functional level and performance did not influence QOL. Conclusions: Measures of ambulatory and physical activity and youth-reported health status separated from the measure of QOL seem helpful in defining the specific health issues of ambulatory youth with CP and have implications for physical activity intervention.

1 January 2008 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
KBKristie F Bjornson
Kristie F Bjornson
BBBasia Belza
Basia Belza
DKDeborah Kartin
Deborah Kartin
RLRebecca G. Logsdon
Rebecca G. Logsdon
JMJohn McLaughlin
John McLaughlin

1 February 2014 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
KBKristie F Bjornson
Kristie F Bjornson
CZChuan Zhou
Chuan Zhou
RSRichard D. Stevenson
Richard D. Stevenson
DCDimitri Christakis
Dimitri Christakis